Published Aug 20, 2026
Bausch + Lomb (BLCO): Premium-IOL Surge, Pharma Scale, and the BHC Path to Full Separation
In-depth research on BLCO covering the business overview, key financial moves, risk frame, and the bottom-line on what changed since the last report.
4,137 words18 min read
Read report